Doctors at the University of New Mexico Hospital used an extracorporeal membrane oxygenation system to treat a cardiac arrest patient in the field for the first time last week, the Albuquerque Journal reports.

A study published just two months after the FDA issued a statement acknowledging a late mortality signal with paclitaxel-coated and -eluting stents and balloons suggests the devices are actually safe in patients with lower extremity artery disease.

Around one in five heart patients in cardiac rehabilitation are depressed, anxious or stressed, according to a new study published in the European Journal of Preventive Cardiology.

Results from the late-breaking TWILIGHT trial suggest that, among high-risk patients who have undergone PCI and completed three months of dual antiplatelet therapy, it’s safer to continue treatment with ticagrelor alone rather than add aspirin to that cocktail.

Teens who use or abuse cannabis could be at risk for a number of cardiac arrhythmias, according to research published in the American Journal of Cardiology, including atrial flutter or fibrillation, palpitations and long QT syndrome.

The New York City Department of Health and Mental Hygiene has expanded its Health Bucks program to allow pharmacists to “prescribe” produce to low-income residents with high blood pressure.

A combo of cryoballoon ablation and novel oral anticoagulants might be a more effective treatment route than standard care for obese AFib patients, who, according to an Oct. 4 study, are less likely to benefit from traditional catheter ablation in the long-term.

Evidence published in BMJ Heart last month supports the idea of an “obesity paradox” in heart failure, further complicating a long-running debate as to whether extra weight can be cardioprotective in patients with established CVD.